Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BSP:PFRM3's 5-Year Yield-on-Cost % is ranked better than 95.65% of 69
companies
in the Medical Distribution industry
Industry Median: 3.09
vs BSP:PFRM3: 10.31
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Profarma Distribuidora De Produtos Farmaceuticos 5-Year Yield-on-Cost % Related Terms
BSP:PFRM3 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Profarma Distribuidora De Produtos Farmaceuticos's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profarma Distribuidora De Produtos Farmaceuticos 5-Year Yield-on-Cost % vs Medical Distribution Industry
Profarma Distribuidora De Produtos Farmaceuticos 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a 5-Year Yield-on-Cost % of 10.31 as of Jul. 26, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. This is 49% above median its historical median of 6.94. Over the past decade, Profarma Distribuidora De Produtos Farmaceuticos' 5-Year Yield-on-Cost % has ranged from 2.00 to 10.31. According to the industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #3 out of 69 companies in the Medical Distribution industry, placing it in the top 4.3%.
Is Profarma Distribuidora De Produtos Farmaceuticos' 5-Year Yield-on-Cost % too high?
Profarma Distribuidora De Produtos Farmaceuticos' current 5-Year Yield-on-Cost % of 10.31 is 49% above median its 10-year median of 6.94. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 10.31. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.09. Profarma Distribuidora De Produtos Farmaceuticos' value of 10.31 is 233.7% above this industry median. Based on the distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #3 out of 69 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #3 out of 69 companies for 5-Year Yield-on-Cost %. This places Profarma Distribuidora De Produtos Farmaceuticos in the top 4% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.09. Profarma Distribuidora De Produtos Farmaceuticos' value of 10.31 is 233.7% above this benchmark. Historically, Profarma Distribuidora De Produtos Farmaceuticos' own 5-Year Yield-on-Cost % has ranged from 2.00 to 10.31 over the past decade. While the company's 10-year median is 6.94 vs. the industry median of 3.09, Profarma Distribuidora De Produtos Farmaceuticos has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.09, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profarma Distribuidora De Produtos Farmaceuticos's current 5-Year Yield-on-Cost % of 10.31 is 233.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profarma Distribuidora De Produtos Farmaceuticos's current 5-Year Yield-on-Cost % is 10.31, which is 49% above median its own 10-year median of 6.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.09, compared to a current price of R$6.25 — trading 22.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 10.31, which is 49% above median its 10-year median of 6.94 and 233.7% above the Medical Distribution industry median of 3.09. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current 5-Year Yield-on-Cost % is 10.31 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued.
The current stock price of R$6.25 is trading 22.7% below its estimated GF Value™ of R$8.09.
GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.
Key valuation signals for BSP:PFRM3:
5-Year Yield-on-Cost %: 10.31 (49% above median its 10-year median of 6.94)
GF Value™: R$8.09 vs. price of R$6.25 (22.7% below fair value)
Industry Position: 233.7% above the Medical Distribution median (#3 of 69)
No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profarma Distribuidora De Produtos Farmaceuticos Business Description
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score
Get the complete analysis for BSP:PFRM3
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PFRM3 has been successfully added to your 
